Comparison of growth parameters at 2 years of corrected gestationalage in preterm infants with and without Metabolic Bone Disease : AnObservational Study

AISHWARYA VENUGOPA0 个研究点目标入组 0 人待定

适应症Health Condition 1: P84- Other problems with newborn

概览

阶段: 未知
干预措施: 未指定
疾病 / 适应症: Health Condition 1: P84- Other problems with newborn
发起方: AISHWARYA VENUGOPA
状态: 尚未招募
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

待定

结束日期

待定

最后更新

2年前

研究类型

Observational

研究者

发起方

AISHWARYA VENUGOPA

入排标准

入选标准

•Group 1 \- Preterm babies \< 32 weeks diagnosed with Metabolic bone disease, now reached 2 years CGA group
•Group 2 \- Preterm babies \< 32 weeks without Metabolic bone disease, now reached 2 years CGA group
•These children will be followed up at the Follow up clinic of SAT hospital, Govt Medical College, Thiruvananthapuram with parental consent for the study.
•The subjects for this study are the children followed up at 2 years corrected gestation age (\+ 1 month), both with and without metabolic bone disease which was obtained from the Department registry maintained for the same. The operational definition used for defining Metabolic Bone Disease was Serum Phosphorus \< 4mg/dl and/or Serum Alkaline phosphatase \> 800IU/L.

排除标准

•Significant systemic illness that affects growth such as Chronic kidney disease, chronic liver disease
•Children diagnosed with skeletal dysplasias
•Lack of parental consent for the study

结局指标

主要结局

未指定

相似试验

已完成

3 期

Growth Retardation In Children With Special Pathological Conditions Or DiseaseEndocrine System Diseases

NCT00163215Pfizer46

尚未招募

不适用

Growth Chart Parameters, Risk FactorsGrowth Disorders

NCT05841264Assiut University600

尚未招募

不适用

Measuring bone growth in bony defects caused by periodontal diseases after treating with growth factors found in blood along with artificial bone powder.

CTRI/2019/01/017043Rajarajeswari Dental College and Hospital

尚未招募

4 期

Comparing the study between two blood products to form new bone.

CTRI/2024/01/061186Dr Angela Johnson

进行中（未招募）

1 期

Validation study for genetic markers for growth hormone treatment in growth hormone deficient and turner syndrome patients

EUCTR2011-000460-10-ESMerck Serono S.A. Geneva461